Intermountain Healthcare Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
67
About the Report
About the Report
Summary
Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, surgical services, behavioral health, neurosciences, and musculoskeletal and its clinical services cover dialysis, environmental, food and nutrition, clinical genetics institute, imaging, integrated care management, laboratory, nursing, pain, patient and provider publications, patient flow, patient safety, pharmacy, rehabilitation, and respiratory care. Intermountain Healthcare operates through hospitals and clinics at various locations including Burley, Smithfield, Tremonton, Logan, Providence, Brigham City, Heber City, among several others. Intermountain is headquartered in Salt Lake City, Utah, the US.
Intermountain Healthcare Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Intermountain Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Tute Genomics Raises Additional USD3.9 Million in Series A1 Venture Financing 12
Ingram Medical Raises USD 30 Million In Series B Venture Financing 13
Partnerships 14
Seven Hospitals and Three Philanthropic Foundations Form Civica RX 14
Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 16
Intermountain Healthcare Inc-Key Competitors 17
Intermountain Healthcare Inc-Key Employees 18
Intermountain Healthcare Inc-Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 21
Recent Developments 22
Strategy And Business Planning 22
Sep 20, 2018: New Intermountain Transformation Center to Lead Healthcare Delivery Advancement 22
Sep 06, 2018: Not-for-profit generic drug company officially established, attracts interest of more than 120 health organizations 23
Mar 01, 2018: Intermountain Healthcare Launches New Company, Expanding Access to Proven Mental Health Integration Approach 24
Corporate Communications 25
Aug 09, 2018: Intermountain Healthcare Names New Leaders to Executive Leadership Team 25
May 15, 2018: Intermountain Healthcare Appoints Rajesh Shrestha to Lead Community-Based Care 26
May 09, 2018: Gail Miller Chosen New Board Chair Of Intermountain Healthcare 27
Nov 02, 2017: Empiric Health Announces Justin Schaper as Chief Technology Officer to Advance Evidence-Based Technology Offering 28
Apr 05, 2017: Intermountain Healthcare Expands Its Top Leadership Team to Better Address Evolving Healthcare Challenges and Patient and Community Needs 29
Mar 01, 2017: Intermountain Healthcare Names Chief Patient Safety and Experience Officer 31
Feb 09, 2017: New Senior Vice President for Intermountain Medical Group and Medical Staff 32
Government and Public Interest 33
Oct 29, 2018: Intermountain Healthcare awarded USD 1 million grant by the National Institutes of Health 33
Sep 17, 2018: New coalition aims to improve US medical diagnoses quality 34
Sep 06, 2018: Three National Foundations Commit USD 30 Million to Civica Rx, a Groundbreaking Effort to Address Shortages and High Prices of Life-Saving Medications 35
Aug 16, 2018: There's no place like home: new study finds patients with low-risk blood clots may be better off receiving treatment at home 36
May 11, 2018: Study Finds New Combined Risk Score More Effectively Predicts Stroke Risk in Patients Who Have Atrial Fibrillation 38
Mar 10, 2018: Transcatheter Aortic Valve Replacement Dramatically Improves Heart Patients' Quality of Life, Study Finds 40
Jan 25, 2018: NCCN Imaging Appropriate Use Criteria Endorsed by Intermountain Healthcare and Will be Included in the Intermountain AUC for Lung Cancer 41
Jan 18, 2018: Trinity Health and Other Leading Health Systems Join Together to Develop a Not-for-profit Generic Drug Company 42
Jan 18, 2018: Ascension joins other leading U.S. health systems to develop not-for-profit generic drug company 44
Nov 20, 2017: NCCN, in Collaboration with Pfizer, Awards Nine Grants for Quality Improvement in Breast Cancer Care 46
Nov 13, 2017: Study Finds People with Certain Blood Types Have Increased Risks of Heart Attack During Periods of High Air Pollution 47
Oct 05, 2017: Intermountain Healthcare Announces an Additional USD 2 Million Donation to Fight Opioid Misuse 49
Oct 01, 2017: Pain management study designed to help patients reduce opioid use receives USD 8.8 million funding 50
Aug 30, 2017: USD 3.8 Million Awarded to Researchers at the University of Utah Health and Intermountain Healthcare 52
Aug 17, 2017: Six Research Teams Receive Intermountain-Stanford Grant Award 53
Jul 11, 2017: New Study Finds That Lymph Node Removal Isn't Necessary For All Melanoma Patients 54
Product News 56
Oct 08, 2017: Intermountain Researchers Launch Major Three-Year Genomics Breast Cancer Study 56
Jul 17, 2017: Intermountain Healthcare and Stanford University Use Precision Medicine Advances to Understand and Treat Cancer Cases 59
May 30, 2018: Intermountain, University of Michigan advance precision medicine for cardiovascular care, cancer 60
Apr 13, 2018: Intermountain Precision Genomics Announces PRECISE Study 61
Other Significant Developments 62
Oct 16, 2018: Intermountain Precision Genomics launches NGS ONE genomics services 62
Aug 15, 2018: Healthcare Innovators professional society reaches member goal of 33 top industry executives for nationwide council 63
Oct 17, 2017: Intermountain Healthcare Announces Precision Health Research Endeavors with 10x Genomics 64
May 23, 2017: Intermountain Healthcare Goes Live on the American Well Exchange 65
May 01, 2017: Intermountain Precision Genomics Announces Translational Science Center 66
Appendix 67
Methodology 67
About GlobalData 67
Contact Us 67
Disclaimer 67
List of Figure
List of Figures
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Intermountain Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Key Facts 2
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Intermountain Healthcare Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Intermountain Healthcare Inc, Medical Devices Deals, 2012 to YTD 2018 10
Intermountain Healthcare Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Tute Genomics Raises Additional USD3.9 Million in Series A1 Venture Financing 12
Ingram Medical Raises USD 30 Million In Series B Venture Financing 13
Seven Hospitals and Three Philanthropic Foundations Form Civica RX 14
Intermountain Healthcare Enters into Agreement with Stanford Genome Technology Center 16
Intermountain Healthcare Inc, Key Competitors 17
Intermountain Healthcare Inc, Key Employees 18
Intermountain Healthcare Inc, Other Locations 19
Intermountain Healthcare Inc, Subsidiaries 21
Intermountain Healthcare Inc, Joint Venture 21
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.